Kyoko Baba,a,b Shinya Kashiwagi,b Mitsuru Nemoto,b Akira Takeda,b Keizo Fukumoto,c and Eiju Uchinumab
A 58-year-old Asian female, 149 cm in height and 79 kg in weight.
Bilateral overgrowth of the upper extremities.
History of present illness
The patient has shown the bilateral overgrowth of the upper extremities since her childhood and has underwent debulking surgery (details unknown) at a hospital in her homeland to reduce tissues twice before coming to Japan. However, overgrowth progressed after every surgery, and pain caused by arm weights persisted. At age 58, the patient visited Japan to obtain the diagnosis and was examined at our departments.
To the extent of her knowledge, none of her relatives had a congenital anomaly of the extremities.
The patient did not desire any invasive tests and underwent whole-body computed tomography (CT) and magnetic resonance imaging (MRI) of the upper extremities.
The patient was diagnosed with MDL based on imaging results and returned to her homeland because follow-up was recommended. The patient did not desire anymore surgery, because of twice recurrences after debulking surgeries.
The bilateral overgrowth of the upper extremities occurred, extending from the shoulders to the fingers (Figures 1 and 2). Both the length and circumference of the upper extremities increased. The overgrowth of the ring and little fingers, as well as of the palm corresponding to the fourth and fifth metacarpal bones was not obvious in the left hand. Any congenital anomalies (e.g. syndactyly) were not found, except the bilateral, disproportional overgrowth of the upper extremities. Surgical cicatrices were found in the extensor aspect of the radius of both upper extremities, in an area between the flexor aspect of the right wrist joint and the palm of the right hand, and in the first interdigit of the left hand.
We could not measure range of motion on severe overgrowth-limb. We checked two-point discrimination (2PD) of her fingers, but it was not strict because of deformity. We could got only one 2DP each on five finger-tips, as below; Right Thumb 6 mm, Right index-finger 9 mm, Right ring-finger 13 mm, Left ring-finger 4 mm, Left little-finger 5 mm.
Adipose tissue hyperplasia was salient in the subcutis and intermuscular stroma of both upper extremities, with bilateral macromelia and macrodactyly (Figures 3 and 4). The ring and little fingers of the left hand were not enlarged. Thyroid atrophy, splenomegaly, adipose infiltration in the pancreas, and bilateral renal microlithiasis were found. Muscles and adipose tissue of the thigh were not atrophied or enlarged.
Physical and imaging findings indicated bilateral and disproportional overgrowth that was localized in the upper extremities. Diagnostic imaging afforded findings suggestive of adipose infiltration in the median nerve. The patient had no family history. Together, the patient was diagnosed with MDL.
MDL is a rare, nonhereditary, and congenital disorder showing the disproportional, progressive overgrowth of mesenchymal tissues including adipose tissue, soft tissue, and bone. In 1925, a patient with MDL of the lower extremities was first reported by Feriz . In 1967, Barsky classified MDL into two types: static type showing overgrowth in proportion to the patient’s growth; and progressive type showing disproportional, progressive overgrowth not in proportion to the patient’s growth ; the latter is considered rarer to develop . Although these two types differ in progression, none of case reports has discussed whether they are of the same pathological entity. Various hypotheses on the etiology of MDL have been postulated, including lipomatous degeneration, fetal circulatory abnormality, damage of the limb bud, somatic cell changes in intrauterine life, and hypertrophy of the involved nerves [7–9]. A recent reports showed an association of MDL with mutations in the PIK3CA gene . PIK3CA-associated segmental overgrowth is confirmed typically in affected tissues. Though, failure to detect a PIK3CA pathogenic variant does not exclude a clinical diagnosis of the PIK3CA-associated segmental overgrowth disorders in individuals with suggestive features . Consequently, it is very difficult to separate these entities. Namely, the etiology of MDL remains unknown.
Usually, MDL is diagnosed based on family history, physical findings, and results from diagnostic imaging . The relatives of the patient with MDL show no congenital anomalies of the extremities because the disorder is nonhereditary in nature. Physical examination indicates the disproportional overgrowth of the extremities in both longitudinal axis and circumference. Diagnostic imaging includes radiography, ultrasonography, CT, and MRI . Among imaging modalities, MRI has been well recognized for its usefulness in a number of case reports [14,15]. Imaging findings include the localized overgrowth of soft tissues (e.g. adipose tissue that is equivalent in signal intensity to normal tissue) and bone tissues, adipose infiltration in the nerves, and ankylosis [6,13]. In a patient who undergoes invasive treatment, furthermore, MDL may be diagnosed along with histopathological examination that demonstrates the presence of fiber-scattered adipose tissue in soft tissues including the nerves, bone marrow, and other tissues [2,12,13]. Furthermore, neurophysiological examination may be conducted additionally that measures nerve conduction velocity and detects reductions in motor and sensory conduction velocities, blocked or reduced segmental conduction, and other changes .
The differential diagnosis of MDL includes fibrolipomatous hamartoma, lymphangiomatosis, hemangiomatosis, Klippel-Trenaunay-Weber syndrome, and Proteus syndrome [16–20]. Among them, the concurrence of MDL and fibrolipomatous hamartoma in the upper extremities has frequently been reported [21–23]; however, the association thereof remains unclear . Other concurrent disorders include clinodactyly, syndactyly, polydactyly, and symphalangism [4,24]. The some authors consider that MDL as a localized form of Proteus syndrome in reports before 2000 [25–27]. Furthermore, there are some confusion of macrodystrophia lipomatosa and fibrolipoma of nerve [9,28]. Although, the most authors believe that the gross changes have as histopathological substrate the proliferation of mesenchymal elements with an excess of adipose/fibro-adipose tissue in the dermis in MDL .
Dysfunction, pain, and cosmetic issues caused by MDL are critical for the patient. However, no radical treatment is available at present [2,12,17]. Some case reports described the amputation of the affected site and debulking surgery . However, no definite therapeutic outcomes have been obtained. Some patients showed improvements in cosmetics and function, and others did not. Several authors mention that overgrowth disorders could be treated in younger patients with the reconstructive surgical intervention and amputation [17,29–31]. On the other hand, according to another reports, recurrence rate of surgery is 33–60% . Probably, several successive procedures will be necessary in order to achieve the desired outcome at the completion of skeletal growth [29–31]. The amount and extension of the interventions will be tailored depending on the evolution of the deformity and the degree of functional impairment . In 2015, a study described the algorithm for the diagnosis and treatment of MDL . According to the algorithm, follow-up of the patient is recommended without performing surgery when finding two or more of the following conditions: onset prior to puberty, affecting 1 or more fingers or toes, and medical emergency .
Presentation of our patient and literature review
We found 131 cases of MDL in 102 case reports and articles according to PubMed that covered published articles between 1952 and 2019. In the vast majority of cases, MDL was unilateral and developed in the fingers or toes. Bilateral MDL developed localized in the fingers or toes of two patients [2,33]. On the other hand, MDL unilaterally affecting the entire upper extremity developed in four paitents [12,34]. To the best of our knowledge, we are the first to report on a case of MDL bilaterally affecting the entire upper extremity. Although PubMed did not list any case of MDL that extended to the same areas of lesions as that of our patient, we diagnosed the patient with MDL based on history of present illness, family history, physical findings, and imaging findings.
Our patient had the macroscopically apparent, disproportional overgrowth of the upper extremities compared with the trunk. To clarify bone overgrowth that is not obvious macroscopically, we measured the lengths of the upper extremity bones on the CT scans. Since we could not make comparisons between the affected upper extremity and the unaffected counterpart because our patient had bilateral MDL, we compared bone lengths measured in our patient with the standard lengths of bones (i.e. lengths of bones calculated from height) of Japanese women in an anthropological article  (Table 1). We employed the anthropological data of Japanese women because we could not find any anthropometric data of the race to which our patients belong. This is the first attempt to compare bone lengths measured on the CT scans with calculated standard bone lengths. The increased lengths of the humerus, radius, and ulna were apparent in our patient. However, we had the impression that long bones did not so elongate as estimated from overgrowth in appearance.
At present, a disorder showing the localized overgrowth of mesenchymal tissues in the extremities is diagnosed as MDL. However, MDL reported to date is diverse: static MDL that does not progress when the patient’s growth ceases; progressive MDL that advances regardless of the patient’s growth; MDL that is localized in the fingers or toes; and MDL that extends to the entire upper or lower extremities. We consider that whether these variants of MDL are of the same pathological entity is debatable. Furthermore, we found a case report that described MDL which skipped to the medial nerve . Therefore, we could not solve the issue about whether or not MDL localized in the fingers or toes is simply detected in the course of its progression to a disorder that extends to the entire upper or lower extremities. We consider that our patient, who showed the overgrowth of mesenchymal tissues in areas not reported to date, potentially attributes to the elucidation of MDL pathology. Comprehensive gene expression analysis by next-generation sequencing on MDL in the future will allow gene expression profiling and will enable a novel therapeutic strategy including gene therapy.Go to:
Our patient did not desire any invasive tests, which impeded us from making auxiliary diagnoses (i.e. histopathological diagnosis and immunohistochemical diagnosis).Go to:
We encountered a patient with MDL that extended bilaterally to the entire upper extremity – a case of MDL that has never been reported in a medical journal, to the best of our knowledge. We reported on the case, along with literature review.
Note: The patient provided consent to be reported in a case report.
1. Feriz H. Macrodystrophia lipomatosa progressiva. Virchows Arch Path Anat. 1926;260(2):308–368. [Google Scholar]2. Albright SB, Wolfswinkel EM, Caceres KJ, et al. . Bilateral macrodystrophia lipomatosa with syndactyly: a case report and literature review. Hand Surg. 2013;18(2):267–272. [PubMed] [Google Scholar]3. Goldman AB, Kaye JJ.. Macrodystrophia lipomatosa: Radiographic diagnosis. AJR Am J Roentgenol. 1977;128(1):101–105. [PubMed] [Google Scholar]4. Aydos SE, Fitoz S, Bökesoy I.. Macrodystrophia lipomatosa of the feet and subcutaneous lipomas. Am J Med Genet A. 2003;119A(1):63–65. [PubMed] [Google Scholar]5. Barsky AJ. Macrodactyly. J Bone Joint Surg Am. 1967;49(7):1255–1266. [PubMed] [Google Scholar]6. Chiang C-L, Tsai M-Y, Chen CK-H.. MRI Diagnosis of Fibrolipomatous Hamartoma of the Median Nerve and Associated Macrodystrophia Lipomatosa. J Chin Med Assoc. 2010;73(9):499–502. [PubMed] [Google Scholar]7. Cerrato F, Eberlin KR, Waters P, et al. . Presentation and treatment of macrodactyly in children. J Hand Surg Am. 2013;38(11):2112–2123. [PubMed] [Google Scholar]8. Tahiri Y, Xu L, Kanevsky J, et al. . Lipofibromatous hamartoma of the median nerve: a comprehensive review and systematic approach to evaluation, diagnosis, and treatment. J Hand Surg Am. 2013;38(10):2055–2067. [PubMed] [Google Scholar]9. Rohilla S, Jain N, Sharma R, et al. . Macrodystrophia lipomatosa involving multiple nerves. J Orthop Traumatol. 2012;13(1):41–45. [PMC free article] [PubMed] [Google Scholar]10. Rios JJ, Paria N, Burns DK, et al. . Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly. Hum Mol Genet. 2013;22(3):444–451. [PMC free article] [PubMed] [Google Scholar]11. Mirzaa G, Conway R, Graham JM, Jr, et al. . PIK3CA-Related Segmental Overgrowth. In: Adam MP, Ardinger HH, Pagon RA, et al. editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2013, 1993–2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK153722/ [Google Scholar]12. Prasetyono T, Hanafi E, Astriana WA.. A review of macrodystrophia lipomatosa: revisitation. Arch Plast Surg. 2015;42(4):391–406. [PMC free article] [PubMed] [Google Scholar]13. Prabhu CS, Madhavi K, Amogh VN, et al. . Macrodystrophia lipomatosa: a single large radiological study of a rare entity. J Clin Imaging Sci. 2019; 94:4–6. [PMC free article] [PubMed] [Google Scholar]14. Blacksin M, Barnes FJ, Lyons MM.. MR diagnosis of macrodystrophia lipomatosa. AJR Am J Roentgenol. 1992;158(6):1295–1297. [PubMed] [Google Scholar]15. Turkington JR, Grey AC.. MR imaging of macrodystrophia lipomatosa. Ulster Med J. 2005;74(1):47–50. [PMC free article] [PubMed] [Google Scholar]16. Brodwater BK, Major NM, Goldner RD, et al. . Macrodystrophia lipomatosa with associated fibrolipomatous hamartoma of the median nerve. Pediatr Surg Int. 2000;16(3):216–218. [PubMed] [Google Scholar]17. Silverman TA, Enzinger FM.. Fibrolipomatous hamartoma of nerve. A clinicopathologic analysis of 26 cases. Am J Surg Pathol. 1985;9(1):7–14. [PubMed] [Google Scholar]18. Price AJ, Compson JP, Calonje E, et al. . Fibrolipomatous hamartoma of nerve arising in the brachial plexus. J Hand Surg Br. 1995;20(1):16–18. [PubMed] [Google Scholar]19. Mehra R, Bhartiya R, Agrawal P, et al. . Macrodystrophia Lipomatosa: Clinico-patho-radiological Correlation. Indian J Med Paediatr Oncol. 2017;38(4):559–562. [PMC free article] [PubMed] [Google Scholar]20. MirastschijskiAltmann U, Lenz-Scharf SO, et al. . Syndromes with focal overgrowth in infancy: Diagnostic approach and surgical treatment. J Plast Surg Hand Surg. 2012;46(1):45–48. 71 [PubMed] [Google Scholar]21. Gouldesbrough DR, Kinny SJ.. Lipofibromatous hamartoma of the ulnar nerve at the elbow: brief report. J Bone Joint Surg Br. 1989;71(2):331–332. [PubMed] [Google Scholar]22. Jacob RA, Buchino JJ.. Lipofibroma of the superficial branch of the radial nerve. J Hand Surg Am. 1989;14(4):704–706. [PubMed] [Google Scholar]23. Agarwal S, Haase SC.. Lipofibromatous hamartoma of the median nerve. J Hand Surg Am. 2013;38(2):392–397. [PubMed] [Google Scholar]24. Tsuge K, Ikuta Y.. Macrodactyly and fibro-fatty proliferation of the median nerve. Hiroshima J Med Sci. 1973;22(1):83–101. [PubMed] [Google Scholar]25. Nishimura G, Kozlowski K.. Proteus syndrome (report of three cases). Australas Radiol. 1990;34(1):47–52. [PubMed] [Google Scholar]26. Azouz DM, Costa T, Fitch N.. Radiologic findings in the Proteus syndrome. Pediatr Radiol. 1987;17(6):481–485. [PubMed] [Google Scholar]27. Burnstein MI, Kottamasu R, Weiss L, et al. . Case report 509: Proteus syndrome. Skeletal Radiol. 1988;17(7):536–538. [PubMed] [Google Scholar]28. Singla V, Virmani V, Tuli P, et al. . Case report: macrodystrophia lipomatosa – Illustration of two cases. Indian J Radiol Imaging. 2008;18(4):298–301. [PMC free article] [PubMed] [Google Scholar]29. Tatu RF, Anuşca DN, Dema ALC, et.al. Surgical treatment in a case of giant macrodystrophia lipomatosa of the forefoot. Rom J Morphol Embryol. 2017;58(3):1115–1119. [PubMed] [Google Scholar]30. Tuzuner T, Parlak AH, Kavak A, et al. A neglected case of macrodystrophia lipomatosa of the foot in an elderly man. J Am Podiatr Med Assoc. 2005;95(5):486–490. [PubMed] [Google Scholar]31. Watt AJ, Chung KC.. Macrodystrophia lipomatosa: A reconstructive approach to gigantism of the foot. J Foot Ankle Surg. 2004;43(1):51–55. [PubMed] [Google Scholar]32. Colonna MR, Guarneri C, do Stagno d’Alcontres F, et al. . Invasive macrodystrophia lipomatosa of the hand. Eur Rev Med Pharmacol Sci. 2014;18(18):2621–2623. [PubMed] [Google Scholar]33. Meer SJ, Nicolai JP, Schut SM, et al. . Bilateral macrodystrophia lipomatosa of the upper extremities with syndactyly and multiple lipomas. J Plast Surg Hand Surg. 2011;45(6):303–306. [PubMed] [Google Scholar]34. Dhanasekaran J, Reddy AK, Sarawagi R, et al. . Imaging features of macrodystrophia lipomatosa: An unusual cause of a brawny arm. BMJ Case Rep. 2014;2014(nov18 2):Bcr2014204899–bcr2014204899. [PMC free article] [PubMed] [Google Scholar]35. Sasou A, Hanihara T.. Regression Equations for Estimating Stature of Modern-Japanese Females. As (J Ser).). 1998;106(1):55–66. [Google Scholar]
Articles from Case Reports in Plastic Surgery & Hand Surgery are provided here courtesy of Taylor & Francis
aDepartment of Plastic Surgery, Kitasato University Medical Center, Saitama, JapanbDepartment of Plastic and Aesthetic Surgery, School of Medicine, Kitasato University, Kanagawa, JapancSaitama Hand and Microsurgery Institute, Saitama, JapanCONTACT Kyoko Baba pj.oc.u-otasatik.dem@ababokoyk, Department of Plastic Surgery, Kitasato University Medical Center, 6-100, Arai, Kitamoto, Saitama364-8501, Japan
Copyright and License
Copyright © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.